During the Fitbit Q1 earnings call, the company confirmed its focus on digital health regardless of the expected decline in sales numbers. Currently, Fitbit is focusing on its new alliance with Google, wherein the two companies will work together to speed up innovation in the digital health space to provide clear EHRs and precise patient data to help the clinicians.
The Patient-Centered Outcomes Researcher Institute (PCORI), a study to look at more effective ways to tackle uncontrolled hypertension using mHealth, was funded $6.5 million to the researchers of the University of California and San Francisco. The research includes whether the patients can care for themselves better at home through mHealth devices, compare to the doctors’ office.
Fitbit announced yesterday that it plans to utilize Google’s new Cloud Healthcare API, in order to continue its push into the world of serious healthcare devices. It’s a bit of a no-brainer as far as partnerships go.
The Food and Drug Administration plans to launch a full-scale version of its digital health precertification program by the end of the year.
Yesterday morning, the FDA published its 17-page first draft of a working model for its pre-certification program for software as a medical device (SaMD). Though still preliminary (the agency is asking for comments by the end of May), the publication comes with some long-awaited details about how the program might work.
On Tuesday, Bothell, Washington-based Steth IO announced the launch of its smartphone-based digital stethoscope.
The mHealth app, designed by researchers at the Worcester Polytechnic Institute, helps obstetric care providers identify perinatal depression in soon-to-be and new mothers and gives them care management tips.
A recent study of so-called 'white coat hypertension' finds that blood pressure readings taken at the doctor's office can be less accurate and more dangerous than readings taken at home with mHealth devices.
Oxygen supply device maker Inogen Inc said on Friday it was notifying 30,000 existing and former customers following a data breach that led to improper access of personal details of some rental clients.
The FDA today approved the first medical device to harness artificial intelligence for the detection of diabetic retinopathy in adults who have diabetes.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.